Zoetis Receives Health Canada Approval for Portela to Alleviate Pain Associated with Osteoarthritis in Cats
Zoetis Receives European Commission Marketing Authorization for Lenivia® to Reduce Pain Associated with Osteoarthritis in Dogs
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
Zoetis Receives European Commission Marketing Authorization for Portela® to Alleviate Pain Associated with Osteoarthritis in Cats
Zoetis Receives Positive Opinion from CVMP for Lenivia® to Reduce Pain Associated with Osteoarthritis in Dogs
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
SAGA Metals Completes Phase 2 of Major Drill Program at the Radar Project in Labrador-Confirms Extensive Oxide Mineralization in All Drill Locations at Trapper North and South Zones & Provides Corporate Update
